Contribute Try STAT+ Today

The fallout from the Dengvaxia scandal reached new heights on Friday as the Philippine Department of Justice found “probable cause” to indict Sanofi (SNY), a half-dozen of its employees, and several current and former Philippines health officials over a series of deaths related to the dengue virus vaccine.

The authorities alleged that charges should be brought for “reckless imprudence resulting (in) homicide” in connection with “irregularities” and lapses in purchasing and approving the use of the Sanofi vaccine, as well as rolling out an immunization program. The company was cited for failing to actively monitor patients and failing to provide assistance after serious adverse events were reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • It seems each of the 20 faces up to 60 years (6 x 10 counts), but given Mr Duarte’s alleged propensity for extra-legal executions, perhaps this counts as a measured legal response? Just a thought ….

Comments are closed.